Singapore markets closed

Crinetics Pharmaceuticals, Inc. (CRNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.37+0.08 (+0.18%)
As of 02:27PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts12121313
Avg. Estimate-0.81-0.8-3.29-3.54
Low estimate-0.94-0.95-3.83-4.86
High estimate-0.68-0.69-2.9-2.77
Year ago EPS-0.85-0.94-3.69-3.29
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts99912
Avg. Estimate260k810k2.13M25.95M
Low estimateN/AN/AN/A3M
High estimate1M5M5M94.69M
Year ago sales2.68M988k4.01M2.13M
Sales growth (year/est)-90.30%-18.00%-46.90%1,118.30%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.81-0.86-0.86-0.86
Actual EPS-0.85-0.94-1.01-0.9
Difference-0.04-0.08-0.15-0.04
Surprise %-4.90%-9.30%-17.40%-4.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.81-0.8-3.29-3.54
7 days ago-0.81-0.8-3.29-3.54
30 days ago-0.81-0.8-3.29-3.54
60 days ago-0.87-0.76-3.4-3.8
90 days ago-0.87-0.76-3.41-3.84
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCRNXIndustrySector(s)S&P 500
Current qtr.4.70%N/AN/AN/A
Next qtr.14.90%N/AN/AN/A
Current year10.80%N/AN/AN/A
Next year-7.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A